Veale Emma L
Medway School of Pharmacy, University of Kent and University of Greenwich, Chatham Maritime, Kent, UK.
Integr Pharm Res Pract. 2024 Jul 29;13:101-114. doi: 10.2147/IPRP.S397844. eCollection 2024.
The world's population is ageing, with the number of those over 60 years expected to represent a fifth of the total population by 2050. Increases in chronic long-term health conditions (LTCs) associated with ageing, and requiring regular but often avoidable medical intervention, are pressurising already overloaded, health and social care systems. Atrial fibrillation (AF) is an LTC, which is most frequently diagnosed in the elderly. An often, asymptomatic condition, AF is associated with a 3- to 5-fold increased risk of severe ischemic stroke. Stroke prevention, with risk-stratified oral anticoagulants (OACs) is the standard recommended care for patients with AF. Stroke avoidance is, however, dependent on persistent adherence to OAC medication, with an adherence rate of >80% considered necessary to achieve optimal health outcomes. Suboptimal adherence to OACs is common, with a third of all AF patients not taking their medication as prescribed. This combined with the short half-life of OACs can result in poor clinical outcomes for patients. Policy makers now consider improving adherence to prescribed medicines for LTCs, a public health priority, to ensure better health outcomes for patients, whilst minimising unnecessary health system costs. Prescribing medicines to treat LTCs, such as AF, is not enough, particularly when the patient may not experience any measurable benefit to the treatment and may instead, experience medication-associated adverse events, including a risk of bleeding. Pharmacists who are experts in medicines management are ideally placed to support medication adherence, to educate, and to improve health outcomes for patients with AF. In this review, I will consider the evidence for poor medication adherence in LTCs and in particular adherence to OACs in patients with AF and highlight the role that pharmacists can play in ensuring optimal adherence and showcase pharmacist-led interventions that effectively address this problem.
全球人口正在老龄化,预计到2050年,60岁以上的人口数量将占总人口的五分之一。与老龄化相关的慢性长期健康状况(LTCs)不断增加,需要定期但往往可以避免的医疗干预,这给已经不堪重负的卫生和社会护理系统带来了压力。心房颤动(AF)是一种LTC,最常在老年人中被诊断出来。AF通常是无症状的,与严重缺血性中风的风险增加3至5倍有关。使用风险分层口服抗凝剂(OACs)预防中风是AF患者的标准推荐治疗方法。然而,避免中风取决于持续坚持服用OAC药物,认为依从率>80%是实现最佳健康结果所必需的。对OACs的依从性欠佳很常见,所有AF患者中有三分之一未按规定服药。这与OACs的短半衰期相结合,可能导致患者临床结果不佳。政策制定者现在认为,提高对LTCs处方药的依从性是一项公共卫生优先事项,以确保患者获得更好的健康结果,同时尽量减少不必要的卫生系统成本。开处方治疗LTCs,如AF,是不够的,特别是当患者可能没有从治疗中获得任何可衡量的益处,反而可能经历与药物相关的不良事件,包括出血风险时。作为药物管理专家的药剂师非常适合支持药物依从性,对AF患者进行教育并改善其健康结果。在这篇综述中,我将考虑LTCs中药物依从性差的证据,特别是AF患者对OACs的依从性,并强调药剂师在确保最佳依从性方面可以发挥的作用,并展示有效解决这一问题的以药剂师为主导的干预措施。